[go: up one dir, main page]

DE69130206D1 - Impfstoff aus reassortiertem rotavirus - Google Patents

Impfstoff aus reassortiertem rotavirus

Info

Publication number
DE69130206D1
DE69130206D1 DE69130206T DE69130206T DE69130206D1 DE 69130206 D1 DE69130206 D1 DE 69130206D1 DE 69130206 T DE69130206 T DE 69130206T DE 69130206 T DE69130206 T DE 69130206T DE 69130206 D1 DE69130206 D1 DE 69130206D1
Authority
DE
Germany
Prior art keywords
rotavirus
rotavirus vaccine
reassortants
gene encoding
bovine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69130206T
Other languages
English (en)
Other versions
DE69130206T2 (de
Inventor
Stanley Plotkin
H Clark
Paul Offit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Philadelphia CHOP
Wistar Institute of Anatomy and Biology
Original Assignee
Childrens Hospital of Philadelphia CHOP
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital of Philadelphia CHOP, Wistar Institute of Anatomy and Biology filed Critical Childrens Hospital of Philadelphia CHOP
Publication of DE69130206D1 publication Critical patent/DE69130206D1/de
Application granted granted Critical
Publication of DE69130206T2 publication Critical patent/DE69130206T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69130206T 1990-07-26 1991-07-25 Impfstoff aus reassortiertem rotavirus Expired - Lifetime DE69130206T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55888490A 1990-07-26 1990-07-26
PCT/US1991/005278 WO1992001784A1 (en) 1990-07-26 1991-07-25 Rotavirus reassortant vaccine

Publications (2)

Publication Number Publication Date
DE69130206D1 true DE69130206D1 (de) 1998-10-22
DE69130206T2 DE69130206T2 (de) 1999-03-04

Family

ID=24231379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130206T Expired - Lifetime DE69130206T2 (de) 1990-07-26 1991-07-25 Impfstoff aus reassortiertem rotavirus

Country Status (7)

Country Link
EP (1) EP0493575B1 (de)
AT (1) ATE171208T1 (de)
CA (1) CA2065847C (de)
DE (1) DE69130206T2 (de)
DK (1) DK0493575T3 (de)
ES (1) ES2122973T3 (de)
WO (1) WO1992001784A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626851A (en) 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
US6210682B1 (en) 1995-06-14 2001-04-03 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
US5900238A (en) * 1995-07-27 1999-05-04 Immunex Corporation Vaccine delivery system
CA2266486C (en) * 1996-09-26 2007-09-25 Merck & Co., Inc. Rotavirus vaccine formulations
WO2007132480A2 (en) * 2006-05-12 2007-11-22 Bharat Biotech International Limited A composition useful as a vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571385A (en) * 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
AU618973B2 (en) * 1987-11-30 1992-01-16 Children's Hospital Foundation, The Novel rotavirus reassortant vaccine

Also Published As

Publication number Publication date
ES2122973T3 (es) 1999-01-01
ATE171208T1 (de) 1998-10-15
CA2065847A1 (en) 1992-01-27
EP0493575A4 (en) 1993-05-05
WO1992001784A1 (en) 1992-02-06
DK0493575T3 (da) 1999-06-14
EP0493575A1 (de) 1992-07-08
DE69130206T2 (de) 1999-03-04
EP0493575B1 (de) 1998-09-16
CA2065847C (en) 2002-02-12

Similar Documents

Publication Publication Date Title
NL300252I2 (nl) Rotavirus-reassortanten-vaccin.
NO20015073D0 (no) Vaksiner
KR890701758A (ko) 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
DE3886506D1 (de) Avirulente mikroben und deren verwendungen.
IL141623A0 (en) Method of dna vaccination
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
ATE170081T1 (de) Humane rotativen, impfstoffe und methoden
DK0939648T3 (da) Rotavirusvaccineformuleringer
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
DE69130206D1 (de) Impfstoff aus reassortiertem rotavirus
ATE157258T1 (de) Zubereitungen und behandlungen von pneumonia in tieren
HU0000362D0 (en) Novel antigenic class of avian reoviruses
HUP9801572A2 (hu) Chlamydia-vakcinák
EP1020516A3 (de) Impfstoff-Antigene von Leptospira zur Vermeidung von Leptospirosis
PL352461A1 (en) Non-active vaccine against a cat disease caused by calciviruses
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
AU2579600A (en) Product and method for obtaining specific immunisation with one or more antigens
ATA211388A (de) Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
Campbell Vaccines for equine influenza
Ijaz et al. Potentials of synthetic peptides as rotavirus vaccine and therapy
Vesikari Rotavirus vaccines for prevention of acute gastroenteritis in young infants

Legal Events

Date Code Title Description
8364 No opposition during term of opposition